bs-83012C [Life Science]
MOMIPP
www.biossusa.com
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Formulation Orange solid

Storage: -20°C

Product Information:

MOMIPP is an inducer of Methuosis, a novel form of nonapoptotic cell death.1 Methuosis is characterized by fusion of macropinocytotic vesiscles into progressively larger vacuoles resulting in a decrease in metabolic activity and rupture of the cell membrane.2 MOMIPP was able to effectively reduce the growth and viability of Temozolomide-resistant glioblastoma and doxorubicin-resistant breast cancer cells at low micromolar concentrations. MOMMIP has also been shown to disrupt vesicular trafficking at the lysosomal nexus resulting in impaired degradation of EGF and LDL receptors, defective processing of procathepsins and accumulation of autophagosomes.3

Description:

CAS Number: 1363421-46-8<br></br>Chemical Name: trans-3-(5-Methoxy-2-methyl-1H-indol-3-yl)-1-(4-pyridinyl)-2-propen-1-one<br></br>Molecular weight: 292.33<br></br>Formula: C18H16N2O2 <br></br>Solubility: DMSO (7 mg/ml)<br></br>Physical Properties: Orange solid<br></br>Purity: 98% by TLC NMR (Conforms)

Size: 10mg, 50mg

Applications: Life Science

For research use only. Not intended for diagnostic or therapeutic use.